15 Results for "

proprotein convertase subtilisin/kexin type 9

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "proprotein convertase subtilisin/kexin type 9" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-120088A
CAS No.: 1632250-50-0
Purity:  99.44%
Target:  

PCSK9

Research Areas:  

Cardiovascular Disease

PF-06446846 hydrochloride is an orally active and highly selective inhibitor of translation of Proprotein convertase subtilisin/kexin type 9 (PCSK9). PF-06446846 hydrochloride inhibits PCSK9 by inducing the ribosome to stall around codon 34 .
loading...
    loading...
7
7 Publications Verification
Cat. No.: HY-120088
CAS No.: 1632250-49-7
Target:  

PCSK9

Research Areas:  

Cardiovascular Disease

PF-06446846 is an orally active proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. PF-06446846 directly and selectively inhibits translation of PCSK9 by stalling the 80S ribosome in the proximity of codon region .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-12402
CAS No.: 489415-96-5
Purity:  99.28%
Target:  

PCSK9

Research Areas:  

Cardiovascular Disease

SBC-115076 is a potent proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. PCSK9 is a proprotein convertase, which plays a crucial role in LDL receptor metabolism .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101832
CAS No.: 1629166-02-4
Purity:  99.55%
Target:  

PCSK9

SBC-110736 is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor extracted from patent WO2014150395A1 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70545A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PCSK9; PC9; Prev. HCHOLA3; Hypercholesterolemia, Autosomal Dominant 3; NARC-1; Neural Apoptosis Regulated convertase 1; subtilisin/kexin-Like Protease PC9; Neural Apoptosis-Regulated convertase 1; FH3; LDLCQ1; proprotein convertase 9; FHCL3; NARC1; proprotein convertase subtilisin/kexin type 9; convertase subtilisin/kexin type 9 Preproprotein
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-148687A
Purity:  93.97%
Target:  

PCSK9

Research Areas:  

Cardiovascular Disease

SPC5001 sodium is a locked nucleic acid (LNA)-modifed antisense oligonucleotide (ASO) complementary to human PCSK9 (proprotein convertase subtilisin/kexin type 9) mRNA. SPC5001 sodium can be used for the research of hypercholesterolemia. SPC5001 sodium sequence: 5′-TGmCTACAAAACmCmCA-3′ .
loading...
    loading...
Cat. No.: HY-112598A
CAS No.: 2334434-49-8
Purity:  98.15%
Target:  

PCSK9

PF-06815345 hydrochloride is an orally active and potent inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9) with an IC50 value of 13.4 μM. PF-06815345 hydrochloride significantly decreases the PCSK9 level in vivo in mouse .
loading...
    loading...
Cat. No.: HY-148687
Target:  

PCSK9

Research Areas:  

Cardiovascular Disease

SPC5001 is a locked nucleic acid (LNA)-modifed antisense oligonucleotide (ASO) complementary to human PCSK9 (proprotein convertase subtilisin/kexin type 9) mRNA. SPC5001 can be used for the research of hypercholesterolemia. SPC5001 sequence: 5′-TGmCTACAAAACmCmCA-3′ .
loading...
    loading...
Cat. No.: HY-158825
CAS No.: 2252375-14-5
Synonyms: CIVI007 sodium
Target:  

PCSK9

Research Areas:  

Metabolic Disease

Cepadacursen sodium is a liver-targeting antisense oligonucleotide (ASO), inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) protein synthesis. Cepadacursen sodium can be used for hypercholesterolemia research and the prevention of atherosclerotic cardiovascular disease (ASCVD).
loading...
    loading...
Cat. No.: HY-112598
CAS No.: 1900686-46-5
Target:  

PCSK9

Research Areas:  

Metabolic Disease

PF-06815345 is an orally active and potent inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9) with an IC50 value of 13.4 μM. PF-06815345 significantly decreases the PCSK9 level in vivo in mouse .
loading...
    loading...
Cat. No.: HY-158827
CAS No.: 2604215-74-7
Target:  

PCSK9

Research Areas:  

Metabolic Disease

AZD8233, a liver-targeting antisense oligonucleotide (ASO), inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) protein synthesis. AZD8233 increases the available LDL receptors by reducing PCSK9 levels, thereby clearing LDL from the blood and decreasing LDL-C levels.
loading...
    loading...
Cat. No.: HY-N10702
PCSK9-IN-9 is an isocoumarins of natural origin. PCSK9-IN-9 can inhibit proprotein convertase subtilisin-kexin type 9 (PCSK9), IDOL, and SREBP2 mRNA expression. PCSK9-IN-9 inhibits PCSK9 with an IC50 value of 11.9 μM .
loading...
    loading...
Cat. No.: HY-P85725
Synonyms: proprotein convertase subtilisin/kexin type 9; Neural apoptosis-regulated convertase 1; NARC-1; proprotein convertase 9; PC9; subtilisin/kexin-like protease PC9;

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P71189
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PCSK9; PC9; Prev. HCHOLA3; Hypercholesterolemia, Autosomal Dominant 3; NARC-1; Neural Apoptosis Regulated convertase 1; subtilisin/kexin-Like Protease PC9; Neural Apoptosis-Regulated convertase 1; FH3; LDLCQ1; proprotein convertase 9; FHCL3; NARC1; proprotein convertase subtilisin/kexin type 9; convertase subtilisin/kexin type 9 Preproprotein
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-101832R
CAS No.: 1629166-02-4
SBC-110736 (Standard) is the analytical standard of SBC-110736 (HY-101832). This product is intended for research and analytical applications. SBC-110736 is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor extracted from patent WO2014150395A1 .
loading...
    loading...
  • 1